Sophiris Bio, Inc. (SPHS) has an overall financial health rating of B- with a composite score of 0 out of 5.
This suggests the company faces some financial challenges worth monitoring. Rating as of 2022-03-25.
| Date | Rating | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2022-03-25 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2022-03-24 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2022-03-23 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2022-03-22 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2022-03-21 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2022-03-18 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2022-03-17 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2022-03-16 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2022-03-15 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2022-03-14 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2022-03-11 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2022-03-10 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 |
